Spoken Alpha
SLDB
Solid Biosciences Inc.
Overview
Solid Biosciences Inc is a Healthcare company operating in Biotechnology with a $932.9M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 1, 2026).
2 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q3 FY20262026-11-01EPS— vs $-0.37—Rev— vs ——EODHD
- Q2 FY20262026-08-05EPS$-0.38 vs $-0.43+11.6%Rev$0 vs ——EODHD
- Q1 FY20262026-05-12EPS$-0.52 vs $-0.44-17.9%Rev$0 vs ——EODHD
- Q4 FY20252026-03-18EPS$-0.53 vs $-0.52-1.9%Rev$0 vs ——EODHD
- Q3 FY20252025-11-02EPS$-0.48 vs $-0.44-9.1%Rev$0 vs ——EODHD
- Q2 FY20252025-08-11EPS$-0.42 vs $-0.49+14.3%Rev$0 vs ——EODHD
- Q1 FY20252025-05-14EPS$-0.59 vs $-0.53-11.3%Rev$0 vs ——EODHD
- Q4 FY20242025-03-10EPS$-1.00 vs $-0.78-27.8%Rev$3.1M vs ——EODHD
- Q3 FY20242024-11-05EPS$-0.79 vs $-0.66-19.7%Rev$0 vs ——EODHD
- Q2 FY20242024-08-12EPS$-0.61 vs $-0.66+7.6%Rev$0 vs ——EODHD
- Q1 FY20242024-05-14EPS$-0.64 vs $-0.60-6.7%Rev$0 vs ——EODHD
- Q4 FY20232024-03-12EPS$-1.00 vs $-0.99-1.0%Rev$4.7M vs ——EODHD
- Q3 FY20232023-11-07EPS$-1.05 vs $-1.20+12.5%Rev$0 vs ——EODHD
- Q2 FY20232023-08-13EPS$-1.26 vs $-1.41+10.6%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-1.54 vs $-1.25-23.2%Rev$0 vs ——EODHD
- Q4 FY20222023-03-22EPS$-0.68 vs $-1.65+58.8%Rev$8.1M vs ——EODHD
- Q3 FY20222022-11-09EPS$-2.71 vs $-1.64-65.2%Rev$0 vs ——EODHD
- Q2 FY20222022-08-10EPS$-3.13 vs $-2.92-7.2%Rev$6.2M vs ——EODHD
- Q1 FY20222022-04-26EPS$-3.30 vs $-2.78-18.7%Rev$1.9M vs ——EODHD
- Q4 FY20212022-03-13EPS$-2.40 vs $-2.91+17.5%Rev$3.2M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-01 | — | $-0.37 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-0.38 | $-0.43 | +11.6% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $-0.52 | $-0.44 | -17.9% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-18 | $-0.53 | $-0.52 | -1.9% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-02 | $-0.48 | $-0.44 | -9.1% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-11 | $-0.42 | $-0.49 | +14.3% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.59 | $-0.53 | -11.3% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-10 | $-1.00 | $-0.78 | -27.8% | $3.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-05 | $-0.79 | $-0.66 | -19.7% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $-0.61 | $-0.66 | +7.6% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-0.64 | $-0.60 | -6.7% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-12 | $-1.00 | $-0.99 | -1.0% | $4.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-1.05 | $-1.20 | +12.5% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-1.26 | $-1.41 | +10.6% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-1.54 | $-1.25 | -23.2% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-22 | $-0.68 | $-1.65 | +58.8% | $8.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-2.71 | $-1.64 | -65.2% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-3.13 | $-2.92 | -7.2% | $6.2M | — | — | EODHD |
| Q1 FY2022 | 2022-04-26 | $-3.30 | $-2.78 | -18.7% | $1.9M | — | — | EODHD |
| Q4 FY2021 | 2022-03-13 | $-2.40 | $-2.91 | +17.5% | $3.2M | — | — | EODHD |
Source: EODHD. SLDB reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Alexander CumboCEO3 yr 9 mono recorded callsCurrent
- Kevin TanCFO3 yr 8 mono recorded callsCurrent
- David T HowtonCOO2 yr 9 mono recorded callsCurrent
- Gabriel BrooksChief Medical Officer2 yr 11 mono recorded callsCurrent
- Paul HerzichChief Technology Officer3 yr 9 mono recorded callsCurrent
- Jessie HanrahanChief Regulatory Officer3 yr 9 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SLDB.
$ curl https://api.spokenalpha.com/v1/companies/SLDBFAQ
Frequently asked about SLDB
Where can I find Solid Biosciences Inc.'s (SLDB) earnings call transcripts?
Spoken Alpha indexes SLDB's earnings call transcripts at https://spokenalpha.com/companies/SLDB. Each call links to attributed speakers and parsed analyst Q&A.
When was Solid Biosciences Inc.'s most recent earnings call?
Solid Biosciences Inc. (SLDB) held its most recent earnings call on 2022-04-30, covering fiscal Q1 2022.
What sector is SLDB in?
Solid Biosciences Inc. (SLDB) operates in the Healthcare sector (Biotechnology industry).